Guthrie Pushes for Information on Alzheimer’s Disease Cures and Treatments
Washington, January 17, 2020
Tags: Health Care
WASHINGTON, D.C. – Congressman Brett Guthrie (KY-02), top Republican on the House Energy and Commerce Committee’s Oversight and Investigations Subcommittee, joined his fellow committee leaders in requesting information on what federal agencies are doing to advance Alzheimer’s Disease treatments and cures.
Guthrie, Energy and Commerce Committee Republican Leader Rep. Greg Walden (OR-02), and Health Subcommittee Republican Leader Rep. Michael Burgess wrote letters to the Department of Health and Human Services (HHS), the Centers for Disease Control and Prevention (CDC), and the National Institutes of Health (NIH).
“We write to request information about the actions that the U.S. Department of Health and Human Services (HHS) has taken to cultivate innovation in Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias (AD/ADRD or Alzheimer’s) research, as well as barriers that stand in the way of discovering treatments or cures for AD/ADRD, and the ways in which Congress can assist in overcoming such barriers,” Guthrie, Walden, and Burgess wrote in their letters.
Congressman Guthrie’s Building Our Largest Dementia (BOLD) Infrastructure for Alzheimer’s Act expanded efforts to combat the disease. In addition, Congressman Guthrie’s Alzheimer’s Accountability Act required scientists at NIH to submit an annual Alzheimer’s research budget proposal directly to Congress. Congress has worked to provide annual funding for Alzheimer’s research, reaching billions in total funding.
However, despite legislation and funding, Alzheimer’s Disease is one of the top 10 causes of death in the United States and the only disease in the top 10 that has no cure or treatment and cannot be slowed.
“Finding a cure or effective treatment for AD/ADRD will continue to require an all-hands-on-deck approach,” Guthrie, Walden, and Burgess continued.
CLICK HERE to read the letter to HHS.
CLICK HERE to read the letter to CDC.
CLICK HERE to read the letter to NIH.